Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment. (Q38019412)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Helen Blanchard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Stephen J. Ralph

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Koichi Ito

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Kimberley Stannard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Elwyn Gabutero

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Shi-Yong Neo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Selda Onturk

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

Cancer and Metastasis Reviews

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

763-778

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10555-012-9388-2

5 February 2020

exact match

0 references

cites work

Galectins: a family of animal beta-galactoside-binding lectins.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectinomics: finding themes in complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectins: structure, function and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Emergence of hormonal and redox regulation of galectin-1 in placental mammals: implication in maternal-fetal immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Structural and functional studies of galectin-1: a novel axonal regeneration-promoting activity for oxidized galectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Characterisation of oxidized recombinant human galectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Oxidized galectin-1 promotes axonal regeneration in peripheral nerves but does not possess lectin properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Oxidized galectin-1 stimulates macrophages to promote axonal regeneration in peripheral nerves after axotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectins in the tumor endothelium: opportunities for combined cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-1: a small protein with major functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-1, a beta-galactoside-binding lectin in Chinese hamster ovary cells. I. Physical and chemical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-3 stimulates cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Mechano-transduction mediated secretion and uptake of galectin-3 in breast carcinoma cells: implications in the extracellular functions of the lectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Apoptosis of T cells mediated by galectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

The role of galectins in the initiation, amplification and resolution of the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

T-cell growth, cell surface organization, and the galectin-glycoprotein lattice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 O-glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-1 induced activation of the mitochondrial apoptotic pathway: evidence for a connection between death-receptor and mitochondrial pathways in human Jurkat T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Expression of galectin-3 modulates T-cell growth and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Expression of a specific glycosyltransferase enzyme regulates T cell death mediated by galectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Normalization of the vasculature for treatment of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Disrupting tumour blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Tumor cells secrete galectin-1 to enhance endothelial cell activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Altered glycosylation of beta 1 integrins associated with reduced adhesiveness to fibronectin and laminin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Imaging cycling tumor hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Molecular pathways: hypoxia response in immune cells fighting or promoting cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

A2A adenosine receptor protects tumors from antitumor T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-1: a link between tumor hypoxia and tumor immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Melanoma-associated genes, MXI1, FN1, and NME1, are hypoxia responsive in murine and human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Tumor-endothelial cell interactions: therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Stepping out of the flow: capillary extravasation in cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8 (+) T cells and reduced cancer cell adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Oncogenic H-Ras enhances DNA repair through the Ras/phosphatidylinositol 3-kinase/Rac1 pathway in NIH3T3 cells. Evidence for association with reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Ras proteins: different signals from different locations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-1(L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

C2-symmetrical thiodigalactoside bis-benzamido derivatives as high-affinity inhibitors of galectin-3: efficient lectin inhibition through double arginine-arene interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Studies of arginine-arene interactions through synthesis and evaluation of a series of galectin-binding aromatic lactose esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Taloside inhibitors of galectin-1 and galectin-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Anti-angiogenesis and anti-tumor activity of recombinant anginex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Anginex, a designed peptide that inhibits angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

The anti-angiogenic peptide anginex greatly enhances galectin-1 binding affinity for glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Oligosaccharide specificity of galectins: a search by frontal affinity chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

N-Glycans in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Inhibiting tumor growth by targeting tumor vasculature with galectin-1 antagonist anginex conjugated to the cytotoxic acylfulvene, 6-hydroxylpropylacylfulvene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Evidence of galectin-1 involvement in glioma chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

C4.4A as a candidate marker in the diagnosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Identification and consequences of galectin-3 expression in pituitary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Evidence of heavy methylation in the galectin 3 promoter in early stages of prostate adenocarcinoma: development and validation of a methylated marker for early diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Tumor-associated galectin-3 modulates the function of tumor-reactive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Decreased galectin-3 expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

A distinct molecular profile associated with mucinous epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-7 in lymphoma: elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Cell cycle regulation by galectin-12, a new member of the galectin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Peracetylated 4-fluoro-glucosamine reduces the content and repertoire of N- and O-glycans without direct incorporation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Anginex-conjugated liposomes for targeting of angiogenic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Crystallization and Preliminary X-ray Diffraction Studies of the Soluble 14 kDa β-Galactoside-binding Lectin from Bovine Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

Vascular Normalization by Loss of Siah2 Results in Increased Chemotherapeutic Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9388-2

10.1007/S10555-012-9388-2

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22706847%20AND%20SRC:MED&resulttype=core&format=json